Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transient sunitinib resistance in gastrointestinal stromal tumors.

Literature DB >> 23697529

Transient sunitinib resistance in gastrointestinal stromal tumors.

Raffaella Bracci, Elena Maccaroni, Stefano Cascinu.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2013 PMID： 23697529 DOI： 10.1056/NEJMc1301237

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Drug rechallenge and treatment beyond progression--implications for drug resistance.

Authors: Elizabeth A Kuczynski; Daniel J Sargent; Axel Grothey; Robert S Kerbel
Journal: Nat Rev Clin Oncol Date: 2013-09-03 Impact factor: 66.675

Review 2. 3D bioprinting for engineering complex tissues.

Authors: Christian Mandrycky; Zongjie Wang; Keekyoung Kim; Deok-Ho Kim
Journal: Biotechnol Adv Date: 2015-12-23 Impact factor: 14.227

3. Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

Authors: Limin Huang; Chaoquan Hu; Mélanie DI Benedetto; Rémi Varin; Jielin Liu; Jian Jin; Li Wang; Jean-Pierre Vannier; Anne Janin; He Lu; Hong Li
Journal: Oncol Lett Date: 2014-12-22 Impact factor: 2.967

4. Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib.

Authors: Limin Huang; Chaoquan Hu; Mélanie Di Benedetto; Rémi Varin; Jielin Liu; Li Wang; Jean-Pierre Vannier; Jian Jin; Anne Janin; He Lu; Hong Li
Journal: Onco Targets Ther Date: 2014-12-04 Impact factor: 4.147

5. Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.

Authors: X Liu; G C George; A M Tsimberidou; A Naing; J J Wheler; S Kopetz; S Fu; S A Piha-Paul; C Eng; G S Falchook; F Janku; C Garrett; D Karp; R Kurzrock; R Zinner; K Raghav; V Subbiah; K Hess; F Meric-Bernstam; D S Hong; M J Overman
Journal: BMC Cancer Date: 2015-10-16 Impact factor: 4.430

Transient sunitinib resistance in gastrointestinal stromal tumors.

Review 1. Drug rechallenge and treatment beyond progression--implications for drug resistance.

Review 2. 3D bioprinting for engineering complex tissues.

3. Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

4. Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib.

5. Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.

Review 6. Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives.

Review 7. Monocyte Transmodulation: The Next Novel Therapeutic Approach in Overcoming Ischemic Stroke?

8. TFE3-PD-L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma.